INSIGHTS

Global Implications and Compliance in the Age of MoCRA

RELATED PRACTICE AREAS
RELATED TOPICS
SHARE

The beauty industry is experiencing a regulatory glow-up, thanks to the Modernization of Cosmetics Regulation Act (MoCRA). With the FDA tightening its grip on cosmetics oversight, the impact is being felt not just in the U.S. but across international borders. From import/export compliance to global harmonization efforts, brands navigating this evolving landscape must be prepared for more than just pretty packaging.

MoCRA and Its Ripple Effect on Global Trade

MoCRA is transforming the U.S. cosmetics industry with stricter safety requirements, good manufacturing practices (GMPs), and mandatory reporting of adverse events. But as the U.S. refines its regulations, cosmetic companies engaged in international trade must ensure they align with global standards.

For exporters, this means adhering to stricter U.S. compliance requirements while simultaneously meeting foreign regulations. A serum that’s FDA-compliant may still need reformulation to satisfy the European Union’s stricter ingredient bans or China’s regulatory nuances. Similarly, importers must provide detailed product safety information, ensuring compliance with MoCRA to avoid delays at U.S. customs.

The Challenge of Regulatory Harmonization

A significant challenge in global cosmetics trade is the lack of regulatory uniformity. The EU’s Cosmetics Regulation has long set the bar high, banning over 1,600 ingredients compared to the U.S.’s historically lenient stance. MoCRA now brings the U.S. closer to these standards, but full alignment is still a distant goal.

Other major markets such as China, Japan, and South Korea each enforce their own compliance frameworks. For example, while China has recently relaxed some requirements like mandatory animal testing for certain products, its regulations still differ significantly from the U.S. and EU. Companies operating internationally must stay ahead of ever-changing rules to ensure market access and avoid costly compliance pitfalls.

Import/Export Compliance: Navigating the Paperwork Maze

Under MoCRA, importers must be diligent in record-keeping and reporting, as the FDA intensifies scrutiny at ports of entry and as fuller enforcement of MoCRA takes shape. Failure to meet documentation requirements can result in products being detained, rejected, or even destroyed. To streamline international trade, companies must:

  • Maintain updated ingredient safety data
  • Ensure GMP certification across all manufacturing sites
  • Comply with country-specific labeling and marketing claims


For exporters, ensuring compliance in multiple jurisdictions requires a robust regulatory strategy. Should companies develop one globally harmonized formulation, or create market-specific versions? Each approach carries its own costs and complexities. 

The Future of Global Cosmetics Compliance

As regulatory bodies worldwide work toward increased alignment, businesses must proactively adjust their compliance strategies. The key to success in this evolving landscape lies in transparency, thorough documentation, and a proactive regulatory approach.

With MoCRA setting a precedent for stricter oversight, the era of loosely regulated beauty products is fading. Brands that embrace compliance as a competitive advantage will thrive, ensuring consumer trust and global market accessibility. The beauty industry’s future is not just about looking good—it’s about playing by the rules, too.

 

For more information on FDA cosmetics compliance under MoCRA, please contact info@garg-law.com.

Garg Law Global Icon

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.
Contact us
Thank you for your interest in Garg Law PLLC.
Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.
If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.